Arthritis of the hip (end stage) - hip replacement (total) and resurfacing arthroplasty (Rev TA2, TA44): evaluation report
01. NICE's response to comments on the Appraisal Consultation Document (ACD)
02. Consultee comments on the ACD - Johnson and Johnson
03. Consultee comments on the ACD - JRI Orthopaedics
04. Consultee comments on the ACD - Smith and Nephew
05. Consultee comments on the ACD - Stryker
06. Consultee comments on the ACD - Wright Medical
07. Consultee comments on the ACD - Zimmer
08. Consultee comments on the ACD - British Hip Society
09. Consultee comments on the ACD - British Orthopaedic Association
10. Consultee comments on the ACD - British Orthopaedic Association - Patient Liaison Group
11. Consultee comments on the ACD - Royal College of Nursing
12. Consultee comments on the ACD - Department of Health
13. Commentator comments on the ACD - Association of British Healthcare Industries
14. Commentator comments on the ACD - MHRA
15. Commentator comments on the ACD - ODEP
16. Public comments on the ACD received via the NICE website
17. Assessment Group commentary on responses to the ACD
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *
Arthritis of the hip (end stage) - hip replacement (total) and resurfacing arthroplasty (Rev TA2, TA44): evaluation report
28 January 2014 (7.43 Mb 56 sec) |
This page was last updated: 24 January 2014